MedPath

Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites

Not Applicable
Recruiting
Conditions
Adult Patients With Mid-term or Long-term Venous Access
Registration Number
NCT04900740
Lead Sponsor
University Hospital Ostrava
Brief Summary

The study will evaluate a new type of cyanoacrylate tissue glue Secure PortIV on the insertion site of the PICC (Peripherally inserted central catheter) or Midline catheters. Fixation of the catheter with the tissue glue should prevent incidents of mechanical and infective phlebitis as well as external migrations of the catheters.

Detailed Description

In the study, 125 subjects will receive the new tissue glue Secure PortIV and 125 subjects will be provided standard care. The tissue glue will be applied immediately after insertion. Evaluation and re-evaluation of the site will be done on the first and seventh day after insertion using VIP and CLISA (Central-Line Insertion Site Assessment) scale and on the seventh day with taking a swab from the insertion site; the external length will be measured on the first and the seventh day, in order to observe the migration or not.

The goal of the study is to evaluate the benefits of the cyanoacrylate tissue glue Secure PortIV in the prevention of mechanical and infective phlebitis and external migration of the catheter.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • 18 years of age
  • need of long-term venous access
  • consent with participation in the study
Exclusion Criteria
  • pediatric population
  • not signing the informed consent form

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The incidence of mechanical and infective phlebitisUp to 6 months

The incidence of mechanical and infective phlebitis will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment

Secondary Outcome Measures
NameTimeMethod
The incidence of external migration of the catheterUp to 6 months

The incidence of external migration of the catheter will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment

Trial Locations

Locations (1)

University Hospital Ostrava

🇨🇿

Ostrava, Moravian-Silesian Region, Czechia

University Hospital Ostrava
🇨🇿Ostrava, Moravian-Silesian Region, Czechia
Jiří Hynčica
Contact
0042059737
jiri.hyncica@fno.cz
Iveta Constantine, Bc., MSc.
Principal Investigator
Andrea Polanská, PhDr., MBA
Sub Investigator
Magda Michalíková, DiS
Sub Investigator
Zuzana Figurová
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.